Evidence map›Paper›PMID 42005239›Full record

ArticleCureus2026

Dueling Malignancies: A Rare Case of Concurrent Chronic Lymphocytic Leukemia (CLL) and Chronic Myeloid Leukemia (CML) in a Multimorbid Elderly Patient.

Meshal Alzahim, Ahmed Alakedi, Omar Almugren, Osama Khoja, Nahla Alias, Alfatih Abdelgader

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Meshal AlzahimPathology, King Saud University, Riyadh, SAU.
Ahmed AlakediLaboratory Medicine, Dr. Sulaiman Al Habib Medical Group, Riyadh, SAU.
Omar AlmugrenLaboratory Medicine, Dr. Sulaiman Al Habib Medical Group, Riyadh, SAU.
Osama KhojaLaboratory Medicine, Dr. Sulaiman Al Habib Medical Group, Riyadh, SAU.
Nahla AliasLaboratory Medicine, Dr. Sulaiman Al Habib Medical Group, Riyadh, SAU.
Alfatih AbdelgaderLaboratory Medicine, Dr. Sulaiman Al Habib Medical Group, Riyadh, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The concurrent presence of multiple hematological malignancies in a single patient is exceptionally rare. Coexisting chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML) in an elderly patient with multiple comorbidities presented unique diagnostic and management challenges. We report a 69-year-old female with a history of type 2 diabetes mellitus, hypertension, chronic kidney disease, and ischemic heart disease. The patient initially presented to an external hospital on 5 January 2025 with shortness of breath and decreased level of consciousness. Initial laboratory investigations at the referring hospital revealed critical values with hemoglobin of 2.9 g/dL and platelet count of 9 ×10⁹/L, requiring urgent transfusion support. During hospitalization at the referring hospital, she developed acute respiratory distress necessitating endotracheal intubation. She was subsequently referred to our institution on 9 January 2025 for further hematologic evaluation. Bone marrow examination showed hypercellularity (70-80%) with trilineage hematopoiesis. Flow cytometric analysis confirmed chronic lymphocytic leukemia (CLL). Cytogenetic studies demonstrated the Philadelphia chromosome in all analyzed metaphases, establishing the diagnosis of chronic myeloid leukemia (CML). This case illustrates the rare simultaneous occurrence of CLL and CML in a patient with significant comorbidities and life-threatening cytopenia at presentation despite a history of leukocytosis and thrombocytosis. The case underscores the importance of comprehensive hematological evaluation, including flow cytometry and cytogenetic analysis, in patients with complex presentations. Managing patients with dual hematological malignancies requires careful consideration of treatment interactions, comorbidities, and complications, highlighting the need for a multidisciplinary approach to optimize outcomes.

Indexed as

chronic lymphocytic leukemia (cll)chronic myeloid leukemia (cml)heme-oncmulti pathologiesrare cancers

Identifiers

PMID42005239
PMCPMC13088208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.